| Date Filed | Type | Description |
| 01/27/2023 |
4
| LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Granted 91,000 restricted stock units
@ $0 |
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Sold 974 shares
@ $3.873, valued at
$3.8k
Sold 1,069 shares
@ $3.529, valued at
$3.8k
|
|
| 02/18/2022 |
4
| LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Sold 831 shares
@ $4.429, valued at
$3.7k
Sold 901 shares
@ $4.189, valued at
$3.8k
Granted 150,000 restricted stock units
@ $0 |
|
| 02/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Granted 57,500 options
@ $25.05, valued at
$1.4M
|
|
| 12/05/2019 |
4
| LeBel Carl (Chief Development Officer) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Granted 23,555 options
@ $3.37, valued at
$79.4k
|
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/22/2016 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc. |
| 09/08/2016 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc. |
| 03/03/2016 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Granted 35,000 options to buy
@ $14.44, valued at
$505.4k
|
|
| 12/22/2015 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Sold 13,189 shares
@ $27.8318, valued at
$367.1k
Sold 8,061 shares
@ $28.3778, valued at
$228.8k
Exercised 16,576 options to buy
@ $6.33, valued at
$104.9k
Exercised 4,674 options to buy
@ $3.17, valued at
$14.8k
|
|
| 09/22/2015 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Sold 21,250 shares
@ $24.3565, valued at
$517.6k
Exercised 4,167 options to buy
@ $1.76, valued at
$7.3k
Exercised 17,083 options to buy
@ $6.33, valued at
$108.1k
|
|
| 06/02/2015 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Granted 389 shares
@ $13.6, valued at
$5.3k
|
|
| 12/12/2014 |
4
| LeBel Carl (Chief Scientific Officer) has filed a Form 4 on Otonomy, Inc.|
Txns:
| Granted 40,000 options to buy
@ $34.12, valued at
$1.4M
|
|
| 02/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2010 |
3
| LeBel Carl (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |